YBX1 and prostate carcinoma: Moreover, the expression of YB-1, which promotes EMT, was inhibited by fisetin in prostate cancer cell line LNCaP in vitro and in the xenograft model of nude mice implanted with the advanced prostate cancer cell line NB26 in vivo [85].